输卵管切除术预防卵巢癌:是否可单独实施?
本文综述了遗传性高风险女性上皮性卵巢癌预防策略的证据,重点讨论输卵管切除联合延迟卵巢切除术(SDO)的新兴数据,并探讨单独输卵管切除术是否可行。输卵管被确认为多数卵巢癌尤其是高级别浆液性癌的起源部位,但SDO在降低卵巢癌风险方面的作用尚未确立,目前仍推荐双侧输卵管卵巢切除术作为高风险女性的标准降风险手术。
要点
- 输卵管是多数卵巢癌尤其是高级别浆液性癌的起源部位。
- SDO可能副作用更少,但在临床试验结果报告前不应在试验外推荐。
- 双侧输卵管卵巢切除术仍是遗传高风险女性降风险手术的首选。
核心结论
- 在SDO对降低卵巢癌风险的作用确立前,不应在临床试验外推荐SDO。
- 双侧输卵管卵巢切除术仍是遗传高风险女性降风险手术的首选治疗。
研究设计与样本
- 综述检索MEDLINE、PubMed、EMBASE和Cochrane数据库,重点关注随机对照试验和大型前瞻性观察性研究。
- 检索关键词包括MeSH词「salpingectomy」「ovarian cancer」「risk-reducing surgery」。
主要发现
- 输卵管已被确立为多数卵巢癌尤其是高级别浆液性癌的起源部位。
- 基于此发现发展了SDO等新预防性手术技术,可能相关副作用更少。
临床怎么用
- 高风险女性降风险手术决策应基于遗传易感性、生育状态和个人偏好个体化制定。
- 决策前应进行 comprehensive consultation(全面咨询)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To summarize published evidence supporting current strategies for the prevention of epithelial ovarian cancer in women with a genetic, elevated risk for the development of this disease, as well as the emerging data on the novel salpingectomy with delayed oophorectomy (SDO) strategy. Furthermore, we will explore whether salpingectomy alone is a viable risk-reducing strategy for these women. We will also discuss current national guidelines for risk-reducing surgery based on patients' individual genetic predisposition. DATA SOURCES: MEDLINE, PubMed, EMBASE, and the Cochrane Database, with a focus on randomized controlled trials and large prospective, observational studies. METHODS OF STUDY SELECTION: The key search terms for our review included Medical Subject Headings: "salpingectomy," "ovarian cancer," and "risk-reducing surgery." TABULATION, INTEGRATION, AND RESULTS: The fallopian tube is now well established as the site of origin for most ovarian cancers, particularly high-grade serous carcinomas. This finding has led to the development of new preventive surgical techniques, such as SDO, which may be associated with fewer side effects. However, until the results of ongoing trials are reported and the impact of SDO on ovarian cancer risk reduction is established, it should not be recommended outside of clinical trials, and bilateral salpingo-oophorectomy remains the treatment of choice for risk-reducing surgery, especially in women with a genetic, high risk for ovarian cancer. CONCLUSION: The decision to undergo risk-reducing surgery among women with an elevated risk for ovarian cancer should be made after comprehensive consultation and individually based on genetic predisposition, childbearing status, and personal preference.
引用
- Boerner T, Long Roche K. Salpingectomy for the Risk Reduction of Ovarian Cancer: Is It Time for a Salpingectomy-alone Approach? J Minim Invasive Gynecol. 2020. PMID: 33038519. doi:10.1016/j.jmig.2020.09.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。